Eli Lilly (LLY) Fundamental Analysis: Revenue, Earnings & Valuation

2.00 / 10

Underperform

The equity presents concerning fundamental picture (2.0/10). Strengths include Fixed assets turnover ratio and Cost of sales ratio (%), offset by weaknesses in PB-ROE. This merits constrained consideration.

Analysis Checks(9/10)

Total operating revenue (YoY growth rate %)

Value44.70

Score2/3

Weight1.82%

1M Return0.32%

Inventory turnover ratio

Value1.04

Score3/3

Weight-3.11%

1M Return-0.51%

PB-ROE

Value8.00

Score0/3

Weight24.80%

1M Return3.62%

Fixed assets turnover ratio

Value3.12

Score2/3

Weight-4.32%

1M Return-0.77%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.97

Score2/3

Weight-6.08%

1M Return-1.10%

Diluted earnings per share (YoY growth rate %)

Value95.99

Score3/3

Weight5.28%

1M Return0.95%

Operating revenue (YoY growth rate %)

Value44.70

Score2/3

Weight1.60%

1M Return0.28%

Cost of sales ratio (%)

Value16.96

Score3/3

Weight5.23%

1M Return0.82%

Asset-MV

Value-0.55

Score2/3

Weight78.19%

1M Return10.36%

Net profit / Total profit (%)

Value80.21

Score2/3

Weight-3.41%

1M Return-0.60%

Is LLY undervalued or overvalued?

LLY scores 2.00/10 on fundamentals and holds a Premium valuation at present. Backed by its 101.16% ROE, 31.67% net margin, 42.10 P/E ratio, 32.75 P/B ratio, and 95.58% earnings growth, these metrics solidify its Underperform investment rating.